2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO12] Mini-Oral Session 12　Hematologic Malignancies 2（Lymphoid）
【E】

Thu. Feb 17, 2022 8:30 AM - 9:20 AM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Kenji Ishitsuka（Department of Hematology and Rheumatology, Kagoshima University），Yasushi Takamatsu（Division of Medical Oncology, Hematology and Infectious Diseases, Department of Internal medicine, Fukuoka University）

[MO12-2] Subcutaneous Epcoritamab+R2in Relapsed/Refractory Follicular Lymphoma: Preliminary Results From a Phase 1/2 Trial

○Kim M. Linton1, BjÖRn Engelbrekt Wahlin2, Sirpa Leppä3, Franck Morschhauser4, Brian Elliott5, Tracy Liu5, Mariana Cota Stirner6, Aqeel Abbas5, Lorenzo Falchi7 (1.The Christie NHS Foundation Trust and Manchester Cancer Research Centre, Manchester, UK, 2.Karolinska Institutet, Stockholm, Sweden, 3.Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland, 4.University of Lille, CHU Lille, Lille, France, 5.Genmab, Princeton, NJ, USA, 6.AbbVie, North Chicago, IL, USA, 7.Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password